Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R21/Matrix-M vaccine in Thai adults
NCT05252845Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of R21/Matrix-M in malaria, sponsored by University of Oxford. Started Jan 2023; status: completed.
02
Drugs
R21/Matrix-M
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05252845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05252845.